HealthCare Africa News December 5, 2022
HealthCare Middle East & Africa Magazine
No.1 Healthcare & Pharma Industry Magazine for Middle East & Africa
AFRICAN NEWS HEADLINES
Dengue fever cases rise in Sudan, the worst outbreak in years
SUDAN?– The Sundanese health ministry has reported that the total number of suspected dengue fever cases in Sudan has exceeded 4,000 as the country struggles to battle one of its worst dengue fever outbreaks in years. . .?Read More
Africa is set to receive its first batch of Mpox vaccine
AFRICA?– The government of the Republic of Korea, through Korea Disease Control and Prevention Agency (KDCA), is set to donate the first batch of the Mpox vaccine to Africa through the Africa CDC?. . .?Read More
Egypt launches new insulin production line for exportation to African countries
EGYPT?– Egypt announced the launch of a new high-capacity insulin production line by Egypt’s Medical Union Pharmaceutical Company (MUP), to export to African countries as soon as it attains self-sufficiency. . .Read More
Namibia revises its medicine policy to be more responsive to emerging health needs
NAMIBIA?– The Ministry of Health and Social Services has launched a revised National Medicines Policy (NMP), after 24 years, to guide and develop pharmaceutical services in the country to meet the requirements of locals in the prevention, diagnosis, and treatment of diseases?. . .Read More
Nagasaki University to train Kenyan scientists on vaccine development
KENYA?– Japan’s Nagasaki University will from 2023 work with KEMRI Graduate School (KGS) in high-level training of KEMRI and Kenyan scientists in vaccine development, from basic science and product development to clinical trials?. . .?Read More
领英推荐
GLOBAL?NEWS HEADLINES
Biocon closes US$3bn deal for Viatris Biosimilars
INDIA?— Biocon has reached a significant milestone after its Biocon Biologics subsidiary closed a $3 billion deal to acquire Viatris' biosimilars business, in what management described as a "historic inflection point" for the Indian player. . .?Read More
Experimental drug appears to slow progression of Alzheimer’s disease
USA?— Experimental drug lecanemab appears to slow the progression of Alzheimer's disease, according to clinical trial results of the drug makers published in the New England Journal of Medicine?. . .?Read More
EU’s new global health strategy underscores stronger international rules and cooperation?
BELGIUM?— The European Union Commission?has unveiled a new global health strategy that is anchored on three pillars propelled by stronger international health rules and health cooperation mechanisms?.?. .?Read More
WHO's Director General announces five new appointments
SWITZERLAND?— Dr. Tedros Adhanom Ghebreyesus, Director General of WHO, has announced the "interim" appointment of five new senior leaders to replace outgoing members of his senior team?.?. .Read More
Pharma giants probe takeover of Horizon Therapeutics
IRELAND?— Horizon Therapeutics, a Dublin-based manufacturer of drugs for rare and inflammatory diseases, has piqued the interest of several large pharmaceutical companies and has confirmed that it is in "highly preliminary" talks with Amgen, Johnson & Johnson, and Sanofi about a possible takeover?.?. .Read More